Approximately 25% of new EWS patients ... (a novel GSK-3β inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such ...

Legalcategory GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln October 9, 2024 Healthcare & Pharmaceuticalscategory GSK, Pfizer RSV vaccine sales fall in US as millions fewer ...

GlaxoSmithKline is under pressure from shareholders ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Teva Pharmaceutical Industries Ltd. ADR 1.52% $19.75B ...

De­spite the rise of a vac­cine skep­tic in the cam­paign of US pres­i­den­tial elec­tion win­ner Don­ald Trump, GSK CEO Em­ma Walm­s­ley be­lieves her com­pa­ny can … ...

The three big airports that serve New York City have proposed allowing concession prices to rise and adding a surcharge to cover higher wages and improved worker benefits. By Patrick McGeehan ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.